Sep 29, 2022

Featuring a slide presentation and related discussion from Dr Amrita Krishnan, including the following topics:

• Key efficacy and safety data with belantamab mafodotin for multiple myeloma (MM) (0:00)
• Guidelines for the prevention and management of keratopathy in patients receiving belantamab mafodotin (3:46)
• Belantamab mafodotin in combination with pomalidomide; recent data and ongoing trials with BCMA-targeted bispecific antibodies (7:30)
• BCMA-targeted CAR (chimeric antigen receptor) T-cell therapies under evaluation for MM (17:07)

CME information and select publications